Very low doses of rituximab in autoimmune hemolytic anemia—an open-label, phase II pilot trial
Authors
- Christian Sillaber
- Miriam M. Moser (ORCID: https://orcid.org/0009-0007-5317-1881)
- Christian Schoergenhofer
- Christa Firbas (ORCID: https://orcid.org/0000-0003-1927-4936)
- Ulla Derhaschnig (ORCID: https://orcid.org/0000-0002-9944-8483)
- Renate Thalhammer
- Bernd Jilma (ORCID: https://orcid.org/0000-0001-5652-7977)
- Ulrich Jäger
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-12-20
- DOI
- https://doi.org/10.3389/fmed.2024.1481333
- Citations
- 3
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 1.36